Companies: 10,795·Total market cap: $144.5T
Minerva Surgical, Inc.

Minerva Surgical, Inc.

UTRSOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$888
P/E Ratio
52W High$0.001
52W Low$0.00001
Overview

Minerva Surgical, Inc. (UTRS) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

utrs · pe ratio · data through Dec 31, 2022

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Minerva Surgical, Inc. (UTRS) measures how much investors pay for each dollar of the company's trailing earnings. UTRS's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$23.68.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31

Forward P/E
N/A
FY2025 est. EPS $-2.80
Based on 1 analyst
EPS (TTM)
-$23.68
TTM · diluted EPS
PEG Ratio
0.00
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Minerva Surgical, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2019 – 2022 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Healthcare Information Services · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Minerva Surgical, Inc.
Minerva Surgical, Inc.You
UTRS
$0MN/A-$23.68
HLK Biotech Holding Group, Inc.
HLK Biotech Holding Group, Inc.
AMHD
$0MN/A
BIMI International Medical Inc.
BIMI International Medical Inc.
BIMI
$0MN/A-$8.40
ContraFect Corporation
ContraFect Corporation
CFRXQ
$0MN/A-$124.97
DMK Pharmaceuticals Corporation
DMK Pharmaceuticals Corporation
DMKPQ
$0MN/A-$12.37
eFFECTOR Therapeutics, Inc.
eFFECTOR Therapeutics, Inc.
EFTR
$0MN/A-$16.37
IMV Inc.
IMV Inc.
IMVIF
$0MN/A-$4.37

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 4 of 4 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2022-12-31Latest
FY2022
$-23.68
2021-12-31
FY2021
$-14.98
2020-12-31
FY2020
$-17.91
2019-12-31
FY2019
$-56.14

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Minerva Surgical, Inc. (UTRS) measures how much investors pay for each dollar of the company's trailing earnings. UTRS's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$23.68.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$23.68 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

UTRS pe ratio · 6 questions

UTRS's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.00 and TTM EPS of -$23.68. Data sourced from Financial Modeling Prep via UTRS's SEC 10-K and 10-Q filings.

UTRS PE ratioWhat is UTRS PE ratioCurrent PE ratio of UTRSUTRS PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Minerva Surgical, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08